Barriers to prescription of sublingual fentanyl tablets for breakthrough cancer pain in an outpatient cancer center

Breakthrough cancer pain (BTcP) is a significant source of distress for patients with cancer. Sublingual fentanyl tablets are the first rapid onset opioid targeted to treat BTcP available in Canada. Objectives: In this study we sought to review the use of this product in consecutive patients for efficacy and safety. Methods: A retrospective chart review was conducted of patients attending an outpatient palliative care clinic who received …